We are monitoring the impact of COVID-19 on Platelet Rich Plasma Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 7669
Share on
Share on

Global Platelet Rich Plasma Market Size, Share, Trends, COVID-19 Impact and Growth Analysis Report – Segmented By Application, Product, Origin and Region – Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 7669
Pages: 175

Global Platelet Rich Plasma Market Size (2020 to 2025)

The size of the Global Platelet Rich Plasma market is estimated to worth USD 499.55 million by 2025 from USD 261.74 million in 2020, registering a CAGR of 13.8% from 2020 to 2025.

Platelet-rich Plasma has purified plasma protein with red blood cells removed from it and used for its higher concentration of growth factors. Platelet-rich plasma can regenerate ligaments and tendon fibers. PRP treatments are tissue healing techniques with a wide range of applications. PRP is a sample collected from one’s blood and placed in an extractor to separate the platelets from various components. The platelet is then used back and injected into and around the injury for healing quickly.

MARKET DRIVERS:

Increasing PRP applications in various treatments such as hair loss, acute sports injuries, knee and thigh sprains, orthopedics, and others are primarily accelerating the global platelet-rich plasma market growth.

Increasing awareness among people regarding the platelet-rich plasma in dental health contributes to the growth of the platelet-rich plasma market. The PRP treatment is expected to surge by 12% from 113,356 procedures in 2017 to nearly 127,394 procedures in 2018.

The influx of investments from various government bodies is another significant factor that catalyzes the growth of the platelet-rich plasma market. Also, benefits associated with PRP, such as faster healing ability and reduced costs related to medical procedures, are boosting the growth of the global platelet-rich plasma business.

Steadily increasing prevalence of orthopedic conditions and the geriatric population are expected to create lucrative growth opportunities to the key market players functioning in the global platelet-rich plasma market during the forecast period. Increasing demand for PRP treatment among the patients diagnosed with hair loss, osteoporotic-related fracture, acute sports injuries, and others are likely to boost growth opportunities for the stakeholders in the world. Increasing applications of PRP in various therapeutic and cosmetic surgeries are providing lucrative opportunities. They are supposed to offer growth opportunities for the key players functioning in the global platelet-rich plasma market. Increasing investments and rise in account of research and development initiatives in countries such as Mexico, India, and Brazil regarding plasma therapy are assumed to expand the number of opportunities for the growth of the platelet-rich plasma market.

MARKET RESTRAINTS:

Manual errors such as the usage of infected syringes lead to infection in the area inserted or extracted the plasma, so eliminating human errors is the critical challenge for the growth of the platelet-rich plasma market. Side effects and pain associated with PRP treatment are challenging the growth of the worldwide platelet-rich plasma market. 

Impact of COVID-19 on the global platelet-rich plasma market:

The disturbance of COVID 19 has positively affected the platelet-rich plasma market. The market is expected to have impressive growth in the upcoming years. Scientists and researchers invented that plasma therapy is one way of treating virus-affected people and recognized better results among the patient's recovering through plasma therapy.  Over the crucial time, scientists and medical professionals highlight their research to find systematic, productive, and possible treatment for COVID 19. The factors mentioned above escalate the PRP market growth during the crisis time. Scientists are rushing to advance antidotes for new coronavirus.  The recovering plasma therapy is developing as a solution to use antibodies from a recovered patient's blood to treat patients who are seriously affected by the virus. The initiation of coronavirus has slowed down the research activity rate in the PRP market. Companied of the PRP market enduring their research in improving plasma therapy for upcoming COVID-19 like viral diseases. The key players intensify research to stop people from being exposed to the infection's second and third waves. Healthcare companies are working effortlessly to make symptoms less ill in patients who recognize coronavirus more than once. Some of the government bodies are executing diverse activities to assist the businesses during the crisis period.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Application, Product, Origin, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This report on the global platelet-rich plasma market has been segmented by Application, Product, and Origin.

Platelet Rich Plasma Market Analysis - By Application:

  • Orthopedics
  • Cosmetic surgery
  • Ophthalmic surgery
  • Neurosurgery

Under this segment, the market is dominated by the Orthopaedics segment, which includes treating diseases like Rotator cuff tears, Achilles tendinopathy, Osteoarthritis. Applications in Cosmetology are also predicted to increase in market value with rising demand for Cosmetic surgery techniques.

Platelet Rich Plasma Market Analysis - By Product:

  • Pure-PRP
  • Leukocyte-Rich
  • Leukocyte-Rich Fibrin

Based on the product, the market is dominated by the pure PRP segment because of less inflammatory responses and effective results in bone regeneration. Leukocyte-rich PRP is expected to rise with a high growth rate owing to its efficiency in healing soft tissue. PRP therapy is the go-to method for soft tissue healing and thus is projected to grow steadily in market value in upcoming years.  

Platelet Rich Plasma Market Analysis - By Origin:

  • Homologous PRP
  • Autologous PRP
  • Allogeneic PRP

Platelet Rich Plasma Market Analysis - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, North America was leading the PRP market globally in 2019. More significant developments in plasma therapy and an increasing number of orthopedic diseases have led to North America being the market leader. Presence of key players and the increasing frequency of cosmetic surgeries and sports injuries, a growing number of people with orthopedic disorders are primarily driving the North American Market. The United States is leading the North American market due to government steps taken to develop blood products and is followed by the Canadian market.

Europe is the second-largest market for PRP and is witnessed to showcase a promising growth rate during the forecast period. The UK market has been led by factors such as the limited existence of domestic manufacturers of PRP. France is the second-largest in the PRP market and is estimated to maintain its position throughout the period.

At the same time, Asia-Pacific is expected to witness a steady rise in market value, with countries like India, China, and Japan contributing heavily to the overall global Platelet Rich Plasma Market. Growing awareness of the PRP market is to drive the market. Also, increasing investments in healthcare infrastructure, the amount spent on healthcare, a large population base with chronic bounds, and orthopedic disorders are responsible for the growth in this region. 

Over the forecast period, the Latin American market is projected to have a steady growth rate. The Brazilian market is accounted to have maximum share of the PRP market wide range of PRP usage for applications like hair loss, knee, and thigh sprains accelerate the market. Mexico and Brazil are to make considerable investments to spread awareness regarding plasma therapy.

The Middle East & Africa region is deemed to have a significant growth rate in the coming years. The growth is due to government increase for safe disposal of unused medications, and awareness about safe disposal of pharmaceuticals and environmental conservation is likely to influence the PRP market growth. 

KEY MARKET PARTICIPANTS:

Some of the key manufacturers leading the Global PRP market include DR. PRP AMERICA, LLC, Glofinn Oy, Zimmer Biomet, DePuy Synthes, Emcyte Corporation, Terumo BCT, Anthrex Inc, T-Biotechnology, and Stryker.

KEY HAPPENINGS IN THIS MARKET IN THE RECENT PAST:

  • The EmCyte Company completed the acquisition of centrepid platelet concentrator from Cellmedix holdings Inc. in March 2020. With this acquisition, the EmCyte Corporation has expanded its product portfolio and strengthened its distribution network. Also, the CEO of the EmCyte was excited that this acquisition will boost its operations regarding biological creativity.
  • In March 2020, Aesthetics Biomedical Inc. announced that it had acquired US patents for Biologic Preserving Composition and Methods of Use. These patents are applied for integrations of skincare into biologics. 
  • Researchers from a medical university located in Dublin have collaborated with another medical university from Poland to analyze the efficacy of PRP as adjuvant therapy for VVF, and the researchers confirmed that the access PRP injections are useful for surgical repair of recurrent VVF.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Orthopedics           

                                5.1.3 Cosmetic Surgery 

                                5.1.4 Ophthalmic surgery             

                                5.1.5 Neurosurgery        

                                5.1.6  Y-o-Y Growth Analysis, By Application        

                                5.1.7  Market Attractiveness Analysis, By Application      

                                5.1.8  Market Share Analysis, By Application       

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Pure-PRP 

                                5.2.3 Leukocyte-Rich     

                                5.2.4 Leukocyte-Rich Fibrin         

                                5.2.5 Y-o-Y Growth Analysis, By Type     

                                5.2.6 Market Attractiveness Analysis, By Type   

                                5.2.7 Market Share Analysis, By Type     

                5.3 Origin                            

                                5.3.1 Introduction           

                                5.3.2 Homologous PRP  

                                5.3.3 Autologous PRP    

                                5.3.4 Allogeneic PRP      

                                5.3.5 Y-o-Y Growth Analysis, By Origin   

                                5.3.6 Market Attractiveness Analysis, By Origin 

                                5.3.7 Market Share Analysis, By Origin   

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Product

                                                6.1.3.4 By Origin

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Product

                                                6.1.4.4 By Origin

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Product

                                                6.1.5.4 By Origin

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Zimmer Biomet                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 DR. PRP AMERICA                    

                8.3 LLC                 

                8.4 Gloffin Oy                   

                8.5 Depuy Synthes                         

                8.6 Emcyte Cororation                  

                8.7 Terumbo BCT                             

                8.8 Anthrex Inc                

                8.9 T-Biotechnology                       

                8.10 Stryker                       

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms By Product and  Others with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Platelet Rich Plasma Market By Region, From 2020 to 2025 (USD Billion)
  2. Global Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  3. Global Pure Market By Region, From 2020 to 2025 (USD Billion)
  4. Global Leukocyte Rich Market By Region, From 2020 to 2025 (USD Billion)
  5. Global Leukocyte rich Fibrin Market By Region, From 2020 to 2025 (USD Billion)
  6. Global Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  7. Global Orthopedics Market By Region, From 2020 to 2025 (USD Billion)
  8. Global Ophthalmic surgery Market By Region, From 2020 to 2025 (USD Billion)
  9. Global Cosmetic surgery Market By Region, From 2020 to 2025 (USD Billion)
  10. Global Neurosurgery Market By Region, From 2020 to 2025 (USD Billion)
  11. North America Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  12. North America Pure Market By Region, From 2020 to 2025 (USD Billion)
  13. North America Leukocyte Rich Market By Region, From 2020 to 2025 (USD Billion)
  14. North America Leukocyte rich Fibrin Market By Region, From 2020 to 2025 (USD Billion)
  15. North America Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  16. North America Orthopedics Market By Region, From 2020 to 2025 (USD Billion)
  17. North America Ophthalmic surgery Market By Region, From 2020 to 2025 (USD Billion)
  18. North America Cosmetic surgery Market By Region, From 2020 to 2025 (USD Billion)
  19. North America Neurosurgery Market By Region, From 2020 to 2025 (USD Billion)
  20. United States Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  21. United States Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  22. Canada Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  23. Canada Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  24. Europe Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  25. Europe Pure Market By Region, From 2020 to 2025 (USD Billion)
  26. Europe Leukocyte Rich Market By Region, From 2020 to 2025 (USD Billion)
  27. Europe Leukocyte rich Fibrin Market By Region, From 2020 to 2025 (USD Billion)
  28. Europe Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  29. Europe Orthopedics Market By Region, From 2020 to 2025 (USD Billion)
  30. Europe Ophthalmic surgery Market By Region, From 2020 to 2025 (USD Billion)
  31. Europe Cosmetic surgery Market By Region, From 2020 to 2025 (USD Billion)
  32. Europe Neurosurgery Market By Region, From 2020 to 2025 (USD Billion)
  33. U.K. Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  34. U.K. Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  35. Germany Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  36. Germany Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  37. France Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  38. France Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  39. Italy Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  40. Italy Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  41. Spain Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  42. Spain Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  43. Asia Pacific Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  44. Asia Pacific Pure Market By Region, From 2020 to 2025 (USD Billion)
  45. Asia Pacific Leukocyte Rich Market By Region, From 2020 to 2025 (USD Billion)
  46. Asia Pacific Leukocyte rich Fibrin Market By Region, From 2020 to 2025 (USD Billion)
  47. Asia Pacific Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  48. Asia Pacific Orthopedics Market By Region, From 2020 to 2025 (USD Billion)
  49. Asia Pacific Ophthalmic surgery Market By Region, From 2020 to 2025 (USD Billion)
  50. Asia Pacific Cosmetic surgery Market By Region, From 2020 to 2025 (USD Billion)
  51. Asia Pacific Neurosurgery Market By Region, From 2020 to 2025 (USD Billion)
  52. Japan Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  53. Japan Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  54. China Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  55. China Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  56. India Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  57. India Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  58. Australia Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  59. Australia Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  60. South Korea Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  61. South Korea Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  62. Latin America Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  63. Latin America Pure Market By Region, From 2020 to 2025 (USD Billion)
  64. Latin America Leukocyte Rich Market By Region, From 2020 to 2025 (USD Billion)
  65. Latin America Leukocyte rich Fibrin Market By Region, From 2020 to 2025 (USD Billion)
  66. Latin America Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  67. Latin America Orthopedics Market By Region, From 2020 to 2025 (USD Billion)
  68. Latin America Ophthalmic surgery Market By Region, From 2020 to 2025 (USD Billion)
  69. Latin America Cosmetic surgery Market By Region, From 2020 to 2025 (USD Billion)
  70. Latin America Neurosurgery Market By Region, From 2020 to 2025 (USD Billion)
  71. Brazil Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  72. Brazil Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  73. Argentina Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  74. Argentina Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  75. Mexico Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  76. Mexico Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  77. Rest of Latin America Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  78. Rest of Latin America Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  79. Middle East and Africa Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  80. Middle East and Africa Pure Market By Region, From 2020 to 2025 (USD Billion)
  81. Middle East and Africa Leukocyte Rich Market By Region, From 2020 to 2025 (USD Billion)
  82. Middle East and Africa Leukocyte rich Fibrin Market By Region, From 2020 to 2025 (USD Billion)
  83. Middle East and Africa Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  84. Middle East and Africa Orthopedics Market By Region, From 2020 to 2025 (USD Billion)
  85. Middle East and Africa Ophthalmic surgery Market By Region, From 2020 to 2025 (USD Billion)
  86. Middle East and Africa Cosmetic surgery Market By Region, From 2020 to 2025 (USD Billion)
  87. Middle East and Africa Neurosurgery Market By Region, From 2020 to 2025 (USD Billion)
  88. Middle East Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  89. Middle East Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)
  90. Africa Platelet Rich Plasma Market By Product, From 2020 to 2025 (USD Billion)
  91. Africa Platelet Rich Plasma Market By Application, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample